Arrow Investment Advisors’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-5,181
Closed -$230K – 66
2025
Q4
$230K Sell
5,181
-194
-4% -$8.36K 0.26% 34
2025
Q3
$227K Buy
+5,375
New +$217K 0.25% 37
2022
Q4
– Sell
-7,068
Closed -$208K – 77
2022
Q3
$208K Sell
7,068
-562
-7% -$17.6K 0.16% 46
2022
Q2
$215K Sell
7,630
-2,120
-22% -$60.3K 0.17% 50
2022
Q1
$304K Buy
9,750
+1,110
+13% +$32.7K 0.23% 40
2021
Q4
$256K Buy
8,640
+365
+4% +$10.7K 0.18% 67
2021
Q3
$248K Buy
8,275
+1,081
+15% +$37.2K 0.16% 80
2021
Q2
$261K Buy
+7,194
New +$267K 0.16% 88

Other funds holding OHI

Arrow Investment Advisors's OHI Position: Q1 2026 in Review

Arrow Investment Advisors sold out of Omega Healthcare (OHI) in Q1 2026, closing a stake of 5,181 shares — an estimated $230K sold.

Arrow Investment Advisors first reported a position in OHI in Q2 2021 and held it in 8 quarters. The position peaked at $304K in Q1 2022. 750 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

  • Arrow Investment Advisors reported no remaining Omega Healthcare position as of Q1 2026 after selling out during the quarter.
  • Arrow Investment Advisors sold 5,181 Omega Healthcare shares in Q1 2026, an estimated $230K.
  • Arrow Investment Advisors first reported a position in Omega Healthcare in Q2 2021 and held it in 8 quarters.
  • Arrow Investment Advisors's Omega Healthcare position peaked at $304K in Q1 2022.
  • 750 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on Arrow Investment Advisors's 13F filing for Q1 2026, filed 4 May 2026.